CA9 and disease arising from reactivation of latent virus: Overall, the results are consistent with a model in which during EBV latent infection of nascent B-lymphocytes EBNA2 transcriptionally activates CA9 expression, while intermittent transition of latent phase to lytic replication cycle by BZLF1 transcriptionally represses CA9 expression and its activity (Fig 11).